Switch to:
More From Other Websites
Kevzara™ (sarilumab) now available in Canada for the Treatment of Adult Patients with Moderately... Feb 28 2017
Sanofi, Lonza to Build $285M Biologics Plant Feb 27 2017
Sanofi's Base Pattern Should Make Investors Happy Feb 27 2017
8:51 am Sanofi & Regeneron (REGN) announce detailed results from... Feb 27 2017
Sanofi and Regeneron to Present New Data on Dupixent® (dupilumab) for Moderate-to-Severe Atopic... Feb 27 2017
Regeneron and Sanofi to Present New Data on DUPIXENT® (dupilumab) for Moderate-to-Severe Atopic... Feb 27 2017
Teva Is Expected to See a Fall in Its Profit Margins in 2017 Feb 23 2017
​Ipswich consultant’s biotech training program expands into Europe Feb 22 2017
Amgen Gets EU Nod for Monthly Repatha Dose Feb 22 2017
What Happened to Sanofi’s Valuation after 4Q16? Feb 21 2017
Sanofi Pasteur: Why Human Vaccines Matter Feb 21 2017
Inside Sanofi’s Consumer Healthcare and Generics Strategy Feb 21 2017
These Prescription Products Matter to Sanofi’s Growth Feb 20 2017
Sanofi’s Unique Foothold in Diabetes and Cardiovascular Feb 20 2017
This Keeps Driving Sanofi’s Growth Feb 20 2017
Inside Sanofi’s Revenues in 4Q16 Feb 17 2017
Parsabiv Is Expected to Boost Amgen’s Revenues in 2017 Feb 17 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK